Journal of Personalized Medicine

J Pers Med

2075-4426

Therapeutic Area

Biotechnology, Genomics, Internal Medicine, Medical Technology, Molecular Medicine, Pharmacogenetics & Pharmacogenomics, Research, Statistics

Academics, Bioengineers, Biomedical Engineers/Technologists, Biomedical Researchers, Clinicians, Computer Scientists, Epidemiologists, Pharmaco-Epidemiologists, Policy Makers, Researchers, Scientists

Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, ‘omics association analysis). Personalized medicine covers the processes of disease development, such as disease risk factors, disease epidemiology and prevention, disease diagnosis, disease treatment, and disease prognosis after treatment. For a comprehensive perspective of primary research, commentaries, and reviews related to personalized medicine, also termed precision medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities. Scope: Topics of interest with a view towards personalized medicine include (but are not limited to) the following: Omics-based studies of disease risk, disease prognosis, and response to therapy; Biomarker identification and application; Drug target discovery and integration with individualized therapy; Pharmacogenomics – genetics and biochemistry of drug uptake, action, and metabolism; Prediction-based drug safety; Novel therapeutics: genetic-based, nanotechnology, targeting strategies; Advancements in Technologies and Resources; Genetic testing, sequencing technologies, and molecular diagnostics; Expression analysis, metabolomics, proteomics; Microbiomes; Genome-wide association studies; Bioinformatics and health informatics; Biostatistics; Artificial intelligence and machine learning; Personalization of omics-based non-drug related health interventions; Regulation and bioethics in personalized medicine; Personalized researches for special populations: pediatrics, adolescents, elderly, etc.; Disease risk factors; Diagnostics in imaging, molecular, pathology, devices assistant, laboratory and others; Personalized medicine in preclinical and clinical medicine, various therapy methods and multidisciplinary therapeutic strategies.

No associations affiliated with this journal

MDPI Publishing

Impact Factor JCR Categories/Rank Electronic Circulation Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Author Submission Guidelines